Successful Treatment of Mycobacterium celatum Pulmonary Disease in an Immunocompetent Patient Using Antimicobacterial Chemotherapy and Combined Pulmonary Resection
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Mycobacterium celatum is a nontuberculous mycobacterium that rarely causes pulmonary disease in immunocompetent subjects. We describe the successful treatment of M. celatum lung disease with antimicobacterial chemotherapy and combined pulmonary resection. A 33-year-old woman was referred to our hospital with a 3-month history of a productive cough. Her medical history included pulmonary tuberculosis 14 years earlier. Her chest X-ray revealed a large cavitary lesion in the left upper lobe. The sputum smear was positive for acid-fast bacilli,and M. celatum was subsequently identified in more than three sputum cultures,using molecular methods. After 1 year of therapy with clarithromycin, ethambutol,and ciprofloxacin, the patient underwent a pulmonary resection for a persistent cavitary lesion. The patient was considered cured after receiving 12 months of postoperative antimycobacterial chemotherapy. There has been no recurrence of disease for 18 months after treatment completion. In summary, M. celatum is an infrequent cause of potentially treatable pulmonary disease in immunocompetent subjects. Patients with M. celatum pulmonary disease who can tolerate resectional surgery might be considered for surgery, especially in cases of persistent cavitary lesions despite antimycobacterial chemotherapy.
Abstract
Mycobacterium celatum is a nontuberculous mycobacterium that rarely causes pulmonary disease in immunocompetent subjects. We describe the successful treatment of M. celatum lung disease with antimicobacterial chemotherapy and combined pulmonary resection. A 33-year-old woman was referred to our hospital with a 3-month history of a productive cough. Her medical history included pulmonary tuberculosis 14 years earlier. Her chest X-ray revealed a large cavitary lesion in the left upper lobe. The sputum smear was positive for acid-fast bacilli,and M. celatum was subsequently identified in more than three sputum cultures,using molecular methods. After 1 year of therapy with clarithromycin, ethambutol,and ciprofloxacin, the patient underwent a pulmonary resection for a persistent cavitary lesion. The patient was considered cured after receiving 12 months of postoperative antimycobacterial chemotherapy. There has been no recurrence of disease for 18 months after treatment completion. In summary, M. celatum is an infrequent cause of potentially treatable pulmonary disease in immunocompetent subjects. Patients with M. celatum pulmonary disease who can tolerate resectional surgery might be considered for surgery, especially in cases of persistent cavitary lesions despite antimycobacterial chemotherapy.
참고문헌 (16)
- Griffith DE, "An official ATS", IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases, 2007, pp.175, 367~416
- Koh WJ, "Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea", Chest, 129, pp.341~348 (2006)
- 박혜윤, "Pulmonary Disease Caused by Mycobacterium xenopi: The First Case in Korea", Yonsei Medical Journal, 48(5), pp.871~875 (2007), 연세대학교의과대학
- Park S, "Clinical significance of Mycobacterium fortuitum isolated from respiratory specimens", Respir Med, 102, pp.437~442 (2008)
- Butler WR, "Mycobacterium celatum sp. nov", Int J Syst Bacteriol, 43, pp.539~548 (1993)
- Christiansen DC, "Mycobacterium celatum, an emerging pathogen and cause of false positive amplified Mycobacterium tuberculosis direct test", Diagn Microbiol Infect Dis, 49, pp.19~24 (2004)
- Bux-Gewehr I, "Fatal pulmonary infection with Mycobacterium celatum in an apparently immunocompetent patient", J Clin Microbiol, 36, pp.587~588 (1998)
- Tjhie JH, "Misidentification and diagnostic delay caused by a false-positive amplified Mycobacterium tuberculosis direct test in an immunocompetent patient with a Mycobacterium celatum infection", J Clin Microbiol, 39, pp.2311~2312 (2001)
- Piersimoni C, "Mycobacterium celatum pulmonary infection in the immunocompetent: case report and review", Emerg Infect Dis, 9, pp.399~402 (2003)
- Kim DK, "Pulmonary infection with Mycobacterium celatum in immunocompetent host: The first case report in Korea", Tuberc Respir Dis, 47, pp.697~703 (1999)
- Lee H, "Species identification of mycobacteria by PCR-restriction fragment length polymorphism of the rpoB gene", J Clin Microbiol, 38, pp.2966~2971 (2000)
- National Committee for Clinical Laboratory Standards, "Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; Approved Standard", Wayne, PA: NCCLS, 2003. Document No. M24-A., ~ (2003)
- Bull TJ, "A new group (type 3) of Mycobacterium celatum isolated from AIDS patients in the London area", Int J Syst Bacteriol, 45, pp.861~862 (1995)
- Emler S, "Disseminated infection with Mycobacterium celatum", Schweiz Med Wochenschr, 126, pp.1062~1065 (1996)
- Zurawski CA, "Pneumonia and bacteremia due to Mycobacterium celatum masquerading as Mycobacterium xenopi in patients with AIDS: an underdiagnosed problem?", Clin Infect Dis, 24, pp.140~143 (1997)
- Fattorini L, "Virulence and drug susceptibility of Mycobacterium celatum", Microbiology, 146, pp.2733~2742 (2000)